Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-15

Clinical Trial Update: Histamine Glutamate Antagonism in Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial results for histamine glutamate antagonism in acute stroke and cerebral edema have been completed. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Histamine Glutamate Antagonist (investigational)

Snippet

Sponsor: University of Florida | Conditions: Acute Cerebrovascular Accident, Cerebral Edema | Phase 2 | Status: COMPLETED | Results posted: 2015-12-15